Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 54, Propineb, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 55, Propyzamide, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 58, Propiconazole, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 77, Zoxamide, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 111, Chlorpyrifos, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 112, Chlorpyrifos-methyl, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 114, Mancozeb, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 121, Clothianidin, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 122, Pethoxamid, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by ‘31 January 2019’;
in the sixth column, expiration of approval, of row 277, Copper compounds, the date is replaced by ‘31 January 2019’.